Pan-cancer analysis of GNG12 in tumors and experimental validation in TNBC

preprint OA: closed
Full text JSON View at publisher
Full text 14,353 characters · extracted from preprint-html · click to expand
Pan-cancer analysis of GNG12 in tumors and experimental validation in TNBC | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Pan-cancer analysis of GNG12 in tumors and experimental validation in TNBC Biao-Feng Shan, Le Zhao, Tao Hu, Jing-Hao Xu, Tong-Xu Zeng, Jian-Ming Tang, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8626202/v1 This work is licensed under a CC BY 4.0 License Status: Under Revision Version 1 posted 12 You are reading this latest preprint version Abstract Guanine Nucleotide-Binding Protein Subunit Gamma-12 (GNG12), a crucial member of the G protein γ subunit family, plays a role in multiple cancers. However, the role of GNG12 in cancer prognosis and immunology remains largely unknown. We analyzed the expression, diagnosis, and prognosis of GNG12 in pan-cancer, particularly in TNBC, using The Sparkle database, UALCAN, Kaplan-Meier Plotter, GEO, and GEPIA tool. The mutations, phosphorylation, and methylation of GNG12 in pan-cancer were investigated through cBioPortal, PhosphoNET, AlphaFold, SangerBox, and UALCAN tool. The relationship between GNG12 expression and signaling pathways, immune cell infiltration, immune checkpoints, and immunomodulators was analyzed through STRING, CancerSEA, KEGG, and GSCA. Finally, the effects of knockdown and overexpression of GNG12 on TNBC proliferation, migration, invasion, and the PI3K/AKT signaling pathway were investigated. GNG12 is lowly expressed in most cancers and is associated with prognosis. GNG12 is correlated with multiple signaling pathways and the immune microenvironment. Overexpression of GNG12 inhibits TNBC proliferation, migration, invasion, and the PI3K/AKT signaling pathway. A comprehensive pan-cancer analysis reveals the potential of GNG12 in tumor-targeted therapy and suggests GNG12 as a promising prognostic and immune pan-cancer biomarker. Health sciences/Biomarkers Biological sciences/Cancer Biological sciences/Computational biology and bioinformatics Biological sciences/Immunology Health sciences/Oncology GNG12 pan-cancer prognosis immunity TNBC Full Text Additional Declarations No competing interests reported. Supplementary Files SupplementaryTableS1.xlsx Cite Share Download PDF Status: Under Revision Version 1 posted Editorial decision: Revision requested 29 Apr, 2026 Reviews received at journal 28 Apr, 2026 Reviews received at journal 27 Apr, 2026 Reviews received at journal 08 Apr, 2026 Reviewers agreed at journal 07 Apr, 2026 Reviewers agreed at journal 12 Mar, 2026 Reviewers agreed at journal 09 Mar, 2026 Reviewers invited by journal 05 Mar, 2026 Editor assigned by journal 05 Mar, 2026 Editor invited by journal 04 Mar, 2026 Submission checks completed at journal 03 Feb, 2026 First submitted to journal 03 Feb, 2026 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8626202","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":602980401,"identity":"6726215b-ba17-463e-b907-281b2986a712","order_by":0,"name":"Biao-Feng Shan","email":"","orcid":"","institution":"Lanzhou University","correspondingAuthor":false,"prefix":"","firstName":"Biao-Feng","middleName":"","lastName":"Shan","suffix":""},{"id":602980402,"identity":"76b3f82b-15d0-4cb7-a2d3-caac22b939a8","order_by":1,"name":"Le Zhao","email":"","orcid":"","institution":"Gansu University of Traditional Chinese Medicine","correspondingAuthor":false,"prefix":"","firstName":"Le","middleName":"","lastName":"Zhao","suffix":""},{"id":602980403,"identity":"cd46daa8-bd8b-4036-b085-4319ae04591b","order_by":2,"name":"Tao Hu","email":"","orcid":"","institution":"Zigong Fourth Peoples Hospital","correspondingAuthor":false,"prefix":"","firstName":"Tao","middleName":"","lastName":"Hu","suffix":""},{"id":602980404,"identity":"a4b86a71-2c02-49da-a16a-02844c71c36a","order_by":3,"name":"Jing-Hao Xu","email":"","orcid":"","institution":"Zouping People's Hospital","correspondingAuthor":false,"prefix":"","firstName":"Jing-Hao","middleName":"","lastName":"Xu","suffix":""},{"id":602980405,"identity":"d7163d6a-c0b9-47ca-926b-391c0a83575f","order_by":4,"name":"Tong-Xu Zeng","email":"","orcid":"","institution":"The second people's hospital of Lanzhou","correspondingAuthor":false,"prefix":"","firstName":"Tong-Xu","middleName":"","lastName":"Zeng","suffix":""},{"id":602980406,"identity":"cc9ae02c-3b8a-4481-a9e0-33ad50823d37","order_by":5,"name":"Jian-Ming Tang","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA9UlEQVRIiWNgGAWjYBACPoYEGPMA44MHYEYCdqUwwAZWAFZ0gNkggUQtDGwSxGlhzzGTYPxhlyfveDqtIuHPYQZ+9hwDhp878GjheWMmwZCQXGx44Oy2Gwk8hxkke94YMPaewaNFIgekhTlxYwNIi8RhBoMbOQbMjG0EtdSDtRQkGBxmsCdSy+HE+QxntzEkJABtkSCkhedZsQVD2vHEDQxnN0skHEjnkTjzrOBgLx4t/OzJG28w2FQnzp9xduOHD3+s5fjbkzc++IlHCwMDh4n0HyBlcOMAmMsDIg7g08DAwP74A4iS72/Ar24UjIJRMApGLgAAGnNSXh+Et1YAAAAASUVORK5CYII=","orcid":"","institution":"First Hospital of Lanzhou University","correspondingAuthor":true,"prefix":"","firstName":"Jian-Ming","middleName":"","lastName":"Tang","suffix":""},{"id":602980407,"identity":"5b590387-e80b-4a68-966d-30e2d77866d0","order_by":6,"name":"Bo Yu","email":"","orcid":"","institution":"The second people's hospital of Lanzhou","correspondingAuthor":false,"prefix":"","firstName":"Bo","middleName":"","lastName":"Yu","suffix":""}],"badges":[],"createdAt":"2026-01-17 13:08:42","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8626202/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8626202/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":104780275,"identity":"487cc18f-ba03-4197-9d26-77469014d922","added_by":"auto","created_at":"2026-03-17 07:51:56","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3085363,"visible":true,"origin":"","legend":"","description":"","filename":"RevisedManuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8626202/v1_covered_99e88619-60f4-41ac-a748-72e8060c1f18.pdf"},{"id":104437002,"identity":"c352d03e-5282-4dac-bf6b-60df25c144c3","added_by":"auto","created_at":"2026-03-11 17:01:09","extension":"xlsx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":11453,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-8626202/v1/36fe74466d78ca8b86af398d.xlsx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Pan-cancer analysis of GNG12 in tumors and experimental validation in TNBC","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"GNG12, pan-cancer, prognosis, immunity, TNBC","lastPublishedDoi":"10.21203/rs.3.rs-8626202/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8626202/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eGuanine Nucleotide-Binding Protein Subunit Gamma-12 (GNG12), a crucial member of the G protein γ subunit family, plays a role in multiple cancers. However, the role of GNG12 in cancer prognosis and immunology remains largely unknown. We analyzed the expression, diagnosis, and prognosis of GNG12 in pan-cancer, particularly in TNBC, using The Sparkle database, UALCAN, Kaplan-Meier Plotter, GEO, and GEPIA tool. The mutations, phosphorylation, and methylation of GNG12 in pan-cancer were investigated through cBioPortal, PhosphoNET, AlphaFold, SangerBox, and UALCAN tool. The relationship between GNG12 expression and signaling pathways, immune cell infiltration, immune checkpoints, and immunomodulators was analyzed through STRING, CancerSEA, KEGG, and GSCA. Finally, the effects of knockdown and overexpression of GNG12 on TNBC proliferation, migration, invasion, and the PI3K/AKT signaling pathway were investigated. GNG12 is lowly expressed in most cancers and is associated with prognosis. GNG12 is correlated with multiple signaling pathways and the immune microenvironment. Overexpression of GNG12 inhibits TNBC proliferation, migration, invasion, and the PI3K/AKT signaling pathway. A comprehensive pan-cancer analysis reveals the potential of GNG12 in tumor-targeted therapy and suggests GNG12 as a promising prognostic and immune pan-cancer biomarker.\u003c/p\u003e","manuscriptTitle":"Pan-cancer analysis of GNG12 in tumors and experimental validation in TNBC","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-03-11 17:01:04","doi":"10.21203/rs.3.rs-8626202/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2026-04-29T10:34:52+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-04-28T15:37:58+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-04-27T05:33:37+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-04-08T15:52:42+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"174322133627323338707762841101095246510","date":"2026-04-07T16:22:25+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"256484484990257544700849947136567528048","date":"2026-03-12T05:44:36+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"189246693379726461330272275485314917406","date":"2026-03-09T09:17:47+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2026-03-06T04:49:50+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-03-06T04:42:03+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2026-03-04T11:40:55+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2026-02-03T20:22:11+00:00","index":"","fulltext":""},{"type":"submitted","content":"Scientific Reports","date":"2026-02-03T20:15:48+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"27fb0d81-3f0a-4b15-a1e1-89231ff3903f","owner":[],"postedDate":"March 11th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"in-revision","subjectAreas":[{"id":64156875,"name":"Health sciences/Biomarkers"},{"id":64156876,"name":"Biological sciences/Cancer"},{"id":64156877,"name":"Biological sciences/Computational biology and bioinformatics"},{"id":64156878,"name":"Biological sciences/Immunology"},{"id":64156879,"name":"Health sciences/Oncology"}],"tags":[],"updatedAt":"2026-04-29T10:40:23+00:00","versionOfRecord":[],"versionCreatedAt":"2026-03-11 17:01:04","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8626202","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8626202","identity":"rs-8626202","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00